-Brigitte Schlegelberger Researcher Activity Profile

Research Author Detailed Information 

Brigitte Schlegelberger Publication Rate By Year

Brigitte Schlegelberger has published 1 paper(s) in 2004, 12 paper(s) in 2007, 8 paper(s) in 2008, for a total of 21 research publications in total.

Brigitte B Schlegelberger Author Information

LAST NAME: schlegelberger

FIRST NAME: Brigitte

INITIALS: b

AFFILIATION:

Papers

Brigitte Schlegelberger's Publication Record

1. Uniparental disomy at chromosome 11p15.5 followed by HRAS mutations in embryonal rhabdomyosarcoma: lessons from Costello syndrome. Year Published: 2007
Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany. christian.kratz@uniklinik-freiburg.de
2. Cytogenetic and molecular study of the PRDX4 gene in a t(X;18)(p22;q23): a cautionary tale. Year Published: 2007
Institute for Cell and Molecular Pathology, Medizinische Hochschule Hannover, Hannover Germany.
3. Chromosomal aberrations in congenital bone marrow failure disorders-an early indicator for leukemogenesis? Year Published: 2007
Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany.
4. Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, deltaTrkA. Year Published: 2007
Department of Experimental Hematology, Hannover Medical School, Hannover, Germany.
5. The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo. Year Published: 2007
6. Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia. Year Published: 2007
7. Mesenteric chloroma with t(16;16) followed by acute myelomonocytic leukemia with clonal evolution. Year Published: 2007
Institute of Cell and Molecular Pathology, Hannover Medical School, Carl-Neuberg Str. 1, Hannover 30625, Germany.
8. Chromosomal aberrations in congenital bone marrow failure disorders--an early indicator for leukemogenesis? Year Published: 2007
Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany. goehring.gudrun@mh-hannover.de
9. Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia. Year Published: 2007
10. Mesenteric chloroma with t(16;16) followed by acute myelomonocytic leukemia with clonal evolution. Year Published: 2007
11. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). Year Published: 2008
Department of Clinical Immunology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany.
12. Mesenteric chloroma with t(16;16) followed by acute myelomonocytic leukemia with clonal evolution. Year Published: 2007
13. Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin. Year Published: 2008
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
14. Chromosomal aberrations in congenital bone marrow failure disorders--an early indicator for leukemogenesis? Year Published: 2007
Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany. goehring.gudrun@mh-hannover.de
15. [Counselling, genetic testing and prevention in women with hereditary breast- and ovarian cancer. Interdisciplinary recommendations of the consortium "Hereditary Breast- and Ovarian Cancer" of the German Cancer AiD] Year Published: 2004
Technische Universität München, Frauenklinik rechts der Isar, Munich.
16. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). Year Published: 2008
Department of Clinical Immunology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany.
17. Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes. Year Published: 2008
Institut für Pathologie, Medizinische Hochschule Hannover, Hannover, Germany. guntram.buesche@arcor.de
18. Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin. Year Published: 2008
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany. templin.christian@mh-hannover.de
19. Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes. Year Published: 2008
20. The differentiation/retrodifferentiation program of human U937 leukemia cells is accompanied by changes of VCP/p97. Year Published: 2008
Dept, of Gynecology, Biochemistry and Tumor Biology Lab, Medical School Hannover, Carl-Neuberg-Str, 1, D - 30625 Hannover, Germany. hass.ralf@mh-hannover.de.
21. The differentiation/retrodifferentiation program of human U937 leukemia cells is accompanied by changes of VCP/p97. Year Published: 2008
Dept. of Gynecology, Biochemistry and Tumor Biology Lab, Medical School Hannover, Carl-Neuberg-Str, 1, D - 30625 Hannover, Germany. bertram.catharina@mh-hannover.de